Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
26,348,834
-
Share change
-
+4,437,763
-
Total reported value
-
$1,236,656,033
-
Put/Call ratio
-
507%
-
Price per share
-
$46.94
-
Number of holders
-
80
-
Value change
-
+$213,109,146
-
Number of buys
-
49
-
Number of sells
-
28
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q3 2022
As of 30 Sep 2022,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,348,834 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, Avidity Partners Management LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, COWEN AND COMPANY, LLC, GENERAL ATLANTIC, L.P., FIRST MANHATTAN CO, and Paradigm Biocapital Advisors LP.
This page lists
80
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.